Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " November 20, 2013":" December 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" November 20, 2013":" December 20, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy Adults
Condition: HIV Infection
Interventions: Biological: ALVAC-HIV;   Biological: AIDSVAX B/E;   Biological: Placebo for ALVAC-HIV;   Biological: Placebo for AIDSVAX B/E;   Biological: Hepatitis B vaccine;   Biological: Tetanus toxoid vaccine;   Biological: Placebo for hepatitis B vaccine;   Biological: Placebo for tetanus vaccine
2 Completed Revealing Increased Axonal Loss in Treated HIV Patients
Condition: HIV Seropositivity
Intervention: Other: ophthalmologic examination and MRI
3 Completed The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia
Condition: HIV Infection
Intervention: Other: Peer‐referral incentive program to increase VMMC uptake
4 Recruiting Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects
Conditions: Acquired Immune Deficiency Syndrome (AIDS);   HIV Infections
Interventions: Drug: ATV;   Drug: DRV;   Drug: Cobicistat;   Drug: BR
5 Unknown  Systems Analysis and Improvement to Optimize pMTCT
Condition: HIV
Intervention: Other: pMTCT systems analysis and improvement
6 Active, not recruiting Niacin on Immune Activation : a Proof-of-concept Study
Condition: HIV
Intervention: Drug: Niacin
7 Unknown  Promoting Uptake and Retention of Option B+ in Malawi
Condition: HIV
Interventions: Other: Community based peer support;   Other: Facility-based Peer Support
8 Active, not recruiting Comprehensive Triaged HIV Prevention in Tanzania
Condition: HIV
Intervention: Behavioral: Comprehensive Triaged HIV Prevention (CTHP)
9 Unknown  Assessment of Group Peer Support to Children With HIV in Vietnam
Condition: Human Immunodeficiency Virus (HIV)
Intervention: Behavioral: Enhanced Treatment Support (ETS)
10 Unknown  Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients
Conditions: Hepacivirus;   HIV Infections
Interventions: Drug: Pentoxifylline;   Drug: Placebo
11 Completed Chloroquine as a Modulator of T Cell Immune Activation
Condition: HIV
Intervention: Drug: Chloroquine
12 Completed Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: HIV Infection;   Monoclonal Antibody, Human;   HIV Antibodies;   VRC01 Monoclonal Antibody;   Neutralizing Antibody
Intervention: Drug: VRC-HIVMAB060-00-AB
13 Completed Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa
Condition: HIV
Interventions: Other: POC CD4 Testing;   Other: CD4 Referral;   Behavioral: Lay Counselor Follow-up;   Behavioral: Clinic Accompaniment;   Behavioral: Clinic Referral;   Behavioral: SMS Reminder;   Behavioral: Circumcision Promotion;   Other: POC VL;   Other: Laboratory based VL assay
14 Completed A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117
Conditions: Healthy;   HIV
Interventions: Biological: 1 mg/kg, single dose IV administration of 3BNC117;   Biological: 3 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, single dose IV administration of 3BNC117;   Biological: 30 mg/kg, single dose IV administration of 3BNC117;   Biological: 10 mg/kg, two doses IV of 3BNC117;   Biological: 30 mg/kg, two doses IV of 3BNC117
15 Active, not recruiting A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS
Condition: HIV
Intervention: Behavioral: Peer Mentoring
16 Recruiting Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy
Condition: HIV/AIDS
Intervention:
17 Active, not recruiting Engaging HIV Patients in Primary Care by Promoting Acceptance
Condition: HIV
Interventions: Behavioral: ABBT;   Other: TAU
18 Active, not recruiting Artefill for the Treatment of HIV-associated Facial Lipoatrophy
Condition: HIV-facial Lipoatrophy
Intervention: Drug: Artefill dermal filler
19 Active, not recruiting Assessment of VAC-3S Therapeutic Properties When Combined With Standard ART in the Course of HIV-1 Infection
Condition: HIV
Intervention: Biological: VAC-3S
20 Unknown  Scale-up of an Internet-Delivered Study for HIV+ Men
Condition: HIV
Intervention: Behavioral: Video treatments

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.